Our commitment to the field of infectious disease is an active one with a promising product pipeline of new therapeutic compounds and treatment options for difficult-to-treat conditions. We are expanding the knowledge base of this therapeutic area and empowering physicians to make evidence-based clinical decisions. Working with the brightest and the best allows us to generate and publish key information on our advances.





  • Product Monograph

    For patient information, please refer to Part III of the Product Monograph

Product Portfolio
Product Portfolio
Research & Development
Research & Development


The Astellas Pharma Canada, Inc. product information and product monographs are being made available to users of this site for informational purposes only, and are intended solely for residents of Canada. These documents contain information on our products as approved by Health Canada. The information in these documents is not intended, nor should it be used, as a substitute for professional medical advice, diagnosis or treatment. You should always seek the advice of your physician, pharmacist or other healthcare professional with respect to any questions you may have regarding your health or a specific medical condition.